Clinical Trial Update: De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA [Phase 2]

View source ↗

Summary

This Phase 2 Mayo Clinic trial evaluates de-escalated adjuvant and definitive radiation therapy for HPV-related oropharyngeal cancer guided by ctHPV-DNA (DART 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Oropharyngeal Cancer
• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: RECRUITING